Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration

BACKGROUND: Glioblastoma is a particularly common and very aggressive primary brain tumour. One of the main causes of therapy failure is the presence of glioblastoma stem cells that are resistant to chemotherapy and radiotherapy, and that have the potential to form new tumours. This study focuses on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zottel, Alja, Jovčevska, Ivana, Šamec, Neja, Mlakar, Jernej, Šribar, Jernej, Križaj, Igor, Skoblar Vidmar, Marija, Komel, Radovan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222267/
https://www.ncbi.nlm.nih.gov/pubmed/32426045
http://dx.doi.org/10.1177/1758835920915302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222267/
https://www.ncbi.nlm.nih.gov/pubmed/32426045
http://dx.doi.org/10.1177/1758835920915302

Ejemplares similares